Gai Jing-jing, Gai Lu-yue, Liu Hong-bin, Wang Zhi-guo, Chen Lian, Sun Zhi-jun, Chen Yun-dai
Department of Cardiology, General Hospital of PLA, Beijing 100039, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1122-6.
The analyze the correlation of heart and kidney biomarkers to different heart and kidney diseases and explore the pathogenesis and classification of cardiorenal syndrome.
This study involved 841 consecutive patients (600 males and 241 females) admitted between January, 2008 and May, 2008, who underwent NT-ProBNP and creatinine tests during hospitalization. The patients were classified according to the clinical diagnosis at the admission and to the status of the heart and kidney biomarkers.
The heart and kidney biomarkers were significantly different between genders. NT-proBNP showed slight elevations in patients with atrial fibrillation, mild non-heart disease, hypertension and angina, but significant elevation in patients with severe non-heart disease. In patients with renal artery stenosis, the heart and kidney biomarkers were moderately increased, which was also seen in patients with diabetes mellitus, myocardial infarction and coronary artery bypass grafting. In dilated cardiomyopathy and rheumatic heart disease, NT-proBNP showed marked increase with only slight increase of creatinine. Patients with chronic kidney disease had the highest NT-proBNP and creatinine levels and the lowest eGFR. The heart and kidneys index increased with the severity of the disease. From Ronco type I to type IV, NT-proBNP rose gradually, but the difference was not statistically significant (P>0.05), and the type I and IV patients had the highest creatinine level; type III involved mainly acute coronary syndrome, heart failure and renal stenosis. According to a modified classification, cardiarenal syndrome was characterized mainly by a marked increase of NT-proBNP, while renalcardiac syndrome by creatinine increases (P<0.05). Acute coronary syndrome, heart failure and renal artery stenosis represented a special entity of cardiorenal syndrome.
Heart and kidney biomarkers and clinical diagnosis are closely related. The heart and kidneys index more accurately reflects the severity of the cardiorenal syndrome. The heart and kidney biomarkers can be used in Ronco classification. The simplified classification is convenient to use and facilitates the clinical decisions of the treatment.
分析心脏和肾脏生物标志物与不同心脏和肾脏疾病的相关性,探讨心肾综合征的发病机制及分类。
本研究纳入了2008年1月至2008年5月期间连续收治的841例患者(男性600例,女性241例),这些患者在住院期间接受了NT-ProBNP和肌酐检测。根据入院时的临床诊断以及心脏和肾脏生物标志物的状况对患者进行分类。
心脏和肾脏生物标志物在性别之间存在显著差异。NT-proBNP在房颤、轻度非心脏疾病、高血压和心绞痛患者中略有升高,但在重度非心脏疾病患者中显著升高。在肾动脉狭窄患者中,心脏和肾脏生物标志物中度升高,糖尿病、心肌梗死和冠状动脉搭桥术患者中也可见到这种情况。在扩张型心肌病和风湿性心脏病患者中,NT-proBNP显著升高,而肌酐仅略有升高。慢性肾脏病患者的NT-proBNP和肌酐水平最高,估算肾小球滤过率(eGFR)最低。心脏和肾脏指标随疾病严重程度增加而升高。从Ronco I型到IV型,NT-proBNP逐渐升高,但差异无统计学意义(P>0.05),I型和IV型患者的肌酐水平最高;III型主要涉及急性冠状动脉综合征、心力衰竭和肾狭窄。根据改良分类,心肾综合征主要表现为NT-proBNP显著升高,而肾心综合征则表现为肌酐升高(P<0.05)。急性冠状动脉综合征、心力衰竭和肾动脉狭窄代表了心肾综合征的一个特殊类型。
心脏和肾脏生物标志物与临床诊断密切相关。心脏和肾脏指标更准确地反映了心肾综合征的严重程度。心脏和肾脏生物标志物可用于Ronco分类。简化分类使用方便,有助于临床治疗决策。